Technology Sharing Title 3

November 05, 2025

info.png

At 12:00 Beijing time on June 12, Burning Rock Medicine was listed on NASDAQ. This leader in the tumor genetic testing track has attracted much attention since the news of its listing came out. Investors' enthusiasm was reflected in the secondary market. The company's stock opened at $22.8, up 38% from the issue price of $16.5, and then rose rapidly, reaching a high of $26.37 during the session. It closed up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Securities served as the underwriter for Burning Rock Medicine this time, successfully helping it obtain orders exceeding $360 million. Among them, the number of retail subscribers exceeded 10,000, and the subscription amount reached $223 million, once again refreshing Tiger Securities' platform's record for retail subscription of US stock IPOs, demonstrating Tiger Securities' unique value as an emerging technology investment bank and its strong business synergy capabilities.

"As entrepreneurs, we can get closer to and understand Chinese startup companies, empathize with the pain points of their listings, and provide them with customized services. In addition, our senior US investment banking team, with its deep understanding of the US market environment and industry, can provide more targeted professional advice to these companies in areas such as finance and valuation. Being a listener and long-term strategic partner for Chinese concept companies, accompanying them to grow together, is what Tiger wants to do." said the relevant person in charge of Tiger Securities' investment banking department. At 12:00 Beijing time on June 12, Burning Rock Medicine was listed on NASDAQ. This leader in the tumor genetic testing track has attracted much attention since the news of its listing came out. Investors' enthusiasm was reflected in the secondary market. The company's stock opened at $22.8, up 38% from the issue price of $16.5, and then rose rapidly, reaching a high of $26.37 during the session. It closed up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Securities served as the underwriter for Burning Rock Medicine this time, successfully helping it obtain orders exceeding $360 million. Among them, the number of retail subscribers exceeded 10,000, and the subscription amount reached $223 million, once again refreshing Tiger Securities' platform's record for retail subscription of US stock IPOs, demonstrating Tiger Securities' unique value as an emerging technology investment bank and its strong business synergy capabilities. "As entrepreneurs, we can get closer to and understand Chinese startup companies, empathize with the pain points of their listings, and provide them with customized services. In addition, our senior US investment banking team, with its deep understanding of the US market environment and industry, can provide more targeted professional advice to these companies in areas such as finance and valuation. Being a listener and long-term strategic partner for Chinese concept companies, accompanying them to grow together, is what Tiger wants to do." said the relevant person in charge of Tiger Securities' investment banking department. At 12:00 Beijing time on June 12, Burning Rock Medicine was listed on NASDAQ. This leader in the tumor genetic testing track has attracted much attention since the news of its listing came out. Investors' enthusiasm was reflected in the secondary market. The company's stock opened at $22.8, up 38% from the issue price of $16.5, and then rose rapidly, reaching a high of $26.37 during the session. It closed up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Securities served as the underwriter for Burning Rock Medicine this time, successfully helping it obtain orders exceeding $360 million. Among them, the number of retail subscribers exceeded 10,000, and the subscription amount reached $223 million, once again refreshing Tiger Securities' platform's record for retail subscription of US stock IPOs, demonstrating Tiger Securities' unique value as an emerging technology investment bank and its strong business synergy capabilities.